B. Metzler Seel. Sohn & Co. Ag Baxter International Inc Transaction History

B. Metzler Seel. Sohn & Co. Ag

  • $10 Billion
  • Q3 2024

A detailed history of B. Metzler Seel. Sohn & Co. Ag transactions in Baxter International Inc stock. As of the latest transaction made, B. Metzler Seel. Sohn & Co. Ag holds 12,073 shares of BAX stock, worth $400,944. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,073
Previous 12,073 -0.0%
Holding current value
$400,944
Previous $403,000 13.65%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$32.87 - $43.55 $16,369 - $21,687
498 Added 4.3%
12,073 $403,000
Q4 2023

Feb 13, 2024
SELL
$31.71 - $38.95 $323,156 - $396,939
-10,191 Reduced 46.82%
11,575 $447,000
Q3 2023

Nov 13, 2023
BUY
$37.32 - $49.29 $36,424 - $48,107
976 Added 4.69%
21,766 $821,000
Q2 2023

Aug 11, 2023
SELL
$39.98 - $47.68 $321,159 - $383,013
-8,033 Reduced 27.87%
20,790 $947,000
Q1 2023

May 10, 2023
BUY
$37.58 - $52.57 $149,906 - $209,701
3,989 Added 16.06%
28,823 $1.17 Million
Q4 2022

Feb 13, 2023
SELL
$49.7 - $57.71 $531,293 - $616,919
-10,690 Reduced 30.09%
24,834 $1.27 Million
Q3 2022

Nov 14, 2022
SELL
$53.86 - $66.8 $360,969 - $447,693
-6,702 Reduced 15.87%
35,524 $1.91 Million
Q2 2022

Aug 12, 2022
BUY
$63.83 - $80.0 $335,809 - $420,880
5,261 Added 14.23%
42,226 $2.71 Million
Q1 2022

May 10, 2022
SELL
$76.85 - $89.45 $458,179 - $533,300
-5,962 Reduced 13.89%
36,965 $2.87 Million
Q4 2021

Feb 11, 2022
BUY
$74.57 - $87.19 $3.2 Million - $3.74 Million
42,927 New
42,927 $3.71 Million

Others Institutions Holding BAX

# of Institutions
1,006
Shares Held
451M
Call Options Held
2.79M
Put Options Held
2.44M
View Full List

About BAXTER INTERNATIONAL INC

BAX Quotes by TradingView
  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.7B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track B. Metzler Seel. Sohn & Co. Ag Portfolio

Follow B. Metzler Seel. Sohn & Co. Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of B. Metzler Seel. Sohn & Co. Ag, based on Form 13F filings with the SEC.

News

Stay updated on B. Metzler Seel. Sohn & Co. Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email